Zika In US & Puerto Rico - Harvard Forum

[niman]

Credit: ©iStock.com/xtrekx The U.S Congress passed a bill yesterday that includes $1.1 billion to fight Zika. Today's Forum will include a discussion of the funding's implications -- and where the money may be best spent. ZIKA IN THE U.S., PUERTO RICO AND BEYOND: Risks and Response  Presented in Collaboration with Reuters Live webcast, TODAY, Thursday, September 29, 2016 SPECIAL TIME: 1-2pm ET

With more than 23,100 cases of Zika in the continental U.S. and U.S. territories — including hard-hit Puerto Rico — this Forum will continue a conversationbegun in March 2016 to discuss the risks and response to the spreading Zika virus. The focus will be on the U.S. and Caribbean, as well as other regions experiencing increases in cases. Public health experts will examine our deepening understanding of how the virus works and how its spread may be controlled; where Congressional funding might be best spent; how vaccines might potentially help; and how public health messaging around the virus may impact at-risk groups, particularly pregnant women. EXPERT PARTICIPANTS Marcia Castro, Associate Professor of Demography, Harvard T.H. Chan School of Public Health, and Member of the Faculty Advisory Committee of the Brazil Studies Program   Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases Cindy Pellegrini, Senior Vice President, Public Policy & Government Affairs, March of Dimes Foundation Celeste Philip, Surgeon General and Secretary, State of Florida MODERATOR Bill Berkrot, Correspondent, Reuters Spread the word: Send our panelists questions in advance to [email protected] We'll be conducting a live chat on The Forum's Zika in the U.S. web page. Tweet us @ForumHSPH #zika We also will stream live on Facebook https://www.facebook.com/Forumhsph/ Tell others about this webcast. Share Tweet Share Forward Watch brief clip of expert recommendations from the March 2016 Forum, The Zika Crisis.  Watch On Demand Eating Disorders, Mental Health and Body Image Health in the American Workplace Organ Transplantation Drowsy Driving Building Resiliency in Age of Terrorism   Listen to These Podcasts at Any Time Health Care Inequalities in America Drug Trials The Zika Crisis Chemical Exposures and the Brain Learn more about The Forum series. Facebook Twitter The Forum Email Us SoundCloud LinkedIn Brief Clips Tumblr

The Forum at the Harvard T.H. Chan School of Public Health A Production of The Leadership Studio Copyright © 2016 The President and Fellows of Harvard College Our mailing address is: Harvard T.H. Chan School of Public Health, The Forum, 677 Huntington Ave., Boston MA 02115 Want to change how you receive these emails? You can update your preferences or unsubscribe from this list

[niman]

Summary

ZIKA IN THE U.S., PUERTO RICO AND BEYOND: Risks and Response 
Presented in Collaboration with Reuters

Live Webcast: Thursday, September 29, 2016

Special Time: 1:00PM-2:00PM ET

With more than 23,100 cases of Zika in the continental U.S. and U.S. territories — including four newly reported non-travel cases in Miami-Dade County, Fla — this Forum will continue a conversation begun in March 2016 to discuss the risks and response to the spreading Zika virus. The focus will be on the U.S. and Caribbean, as well as other regions experiencing increases in cases. Public health experts will examine our deepening understanding of how the virus works and how its spread may be controlled; where Congressional funding might be best spent; how vaccines might potentially help; and how public health messaging around the virus may impact at-risk groups, particularly pregnant women.

Spread the word:
Send our panelists questions in advance to [email protected]
Tweet us @ForumHSPH #ZikaVirus #Zika

Part of: Policy Controversies.

Presented in Collaboration with Reuters

Image Credit: iStockphoto.com | xtrekx

https://theforum.sph.harvard.edu/events/zika-in-the-u-s-puerto-rico-and-beyond/

[niman]

Marcia Castro

Dr. Castro was a panelist for the Forum’s discussion on the The Zika Crisis and Zika in the U.S., Puerto Rico, and Beyond.

Marcia Castro is a founding member of the Wittgenstein Centre for Demography and Global Human Capital’s Scientific Advisory Board. At Harvard, Castro serves as a member of the Faculty Advisory Committee of the Brazil Studies Program, a member of the Brazil Studies Program Steering Group of the David Rockefeller Center for Latin American Studies (DRCLAS), and a member of the Center for Geographic Analysis (CGA) Steering Committee. Her research focuses on:

• the identification of social, biological, and environmental risks associated with vector-borne diseases in the tropics
• modeling determinants of malaria transmission, with particular emphasis on generating evidence for better control strategies
• expansion of the Brazilian Amazon frontier and the social and environmental impacts of large-scale development projects implemented in the region
• urbanization and health
• use of spatial analysis in the Social Sciences
• population dynamics and mortality models

Castro has applied geographical information systems, remote sensing, and spatial statistics to her research, as well as proposed novel methods in spatial analysis. She has done extensive work in the Brazilian Amazon, and has experience working in Africa. Since 2004, she has been working on the Dar es Salaam Urban Malaria Control Program, promoting the use of environmental management approaches to improve urban health. She is currently working on a project that is measuring health, poverty and place by modeling inequalities in Accra, Ghana using RS and GIS. She is also investigating the use of remotely sensed imagery to predict urban malaria in Dar es Salaam, Tanzania. Castro is leading a project to assess the malaria poverty vicious cycle, and she started a project to propose a new methodology to assess spatio-temporal trends in a scenario of multiple control interventions. She is also working on the issues of human mobility and asymptomatic malaria infections in the Brazilian Amazon, as well as on the potential impacts of extreme climatic events on malaria transmission in the Amazon.

[niman]

Anthony Fauci

Dr. Fauci was a panelist for the Forum’s discussions on Ebola, The Zika Crisis, and Zika in the U.S., Puerto Rico, and Beyond.

Anthony Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2013 was approximately $4.5 billion. Dr. Fauci serves as one of the key advisors to the White House and Department of Health and Human Services on global AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats such as pandemic influenza. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), which has already been responsible for saving millions of lives throughout the developing world.

Dr. Fauci also is the long-time chief of the NIAID Laboratory of Immunoregulation. He has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response. In addition, Dr. Fauci is widely recognized for delineating the precise mechanisms whereby immunosuppressive agents modulate the human immune response. He developed effective therapies for formerly fatal inflammatory and immune-mediated diseases such as polyarteritis nodosa, granulomatosis with polyangiitis (formerly Wegener’s granulomatosis), and lymphomatoid granulomatosis. A 1985 Stanford University Arthritis Center Survey of the American Rheumatism Association membership ranked the work of Dr. Fauci on the treatment of polyarteritis nodosa and granulomatosis with polyangiitis as one of the most important advances in patient management in rheumatology over the previous 20 years.

Dr. Fauci has made seminal contributions to the understanding of how HIV destroys the body’s defenses leading to its susceptibility to deadly infections. Further, he has been instrumental in developing highly effective strategies for the therapy of patients living with HIV/AIDS, as well as for a vaccine to prevent HIV infection. He continues to devote much of his research time to identifying the nature of the immunopathogenic mechanisms of HIV infection and the scope of the body’s immune responses to HIV.

In 2003, an Institute for Scientific Information study indicated that in the 20-year period from 1983 to 2002, Dr. Fauci was the 13th most-cited scientist among the 2.5 to 3 million authors in all disciplines throughout the world who published articles in scientific journals during that time frame. Dr. Fauci was the world’s 10th most-cited HIV/AIDS researcher in the period from 1996 through 2006.

Dr. Fauci has delivered major lectures all over the world and is the recipient of numerous prestigious awards, including the Presidential Medal of Freedom, the National Medal of Science, the George M. Kober Medal of the Association of American Physicians, the Mary Woodard Lasker Award for Public Service, the Albany Medical Center Prize in Medicine and Biomedical Research, the Robert Koch Gold Medal, the Prince Mahidol Award, and 38 honorary doctoral degrees from universities in the United States and abroad.

Dr. Fauci is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the Institute of Medicine, and the American Philosophical Society, as well as other professional societies including the American College of Physicians, The American Society for Clinical Investigation, the Association of American Physicians, the Infectious Diseases Society of America, The American Association of Immunologists, and the American Academy of Allergy, Asthma & Immunology. He serves on the editorial boards of many scientific journals; as an editor of Harrison’s Principles of Internal Medicine; and as author, coauthor, or editor of more than 1,200 scientific publications, including several textbooks.

 

[niman]

Cindy Pellegrini

Ms. Pellegrini was a participant for the Forum’s discussion on Zika in the U.S., Puerto Rico, and Beyond.

Cynthia Pellegrini is Senior Vice President for Public Policy and Government Affairs at the March of Dimes. In this capacity, Ms. Pellegrini oversees all March of Dimes advocacy efforts at the federal level and in all 50 States, the District of Columbia and Puerto Rico. She also guides the organization’s research on maternal and child health policy issues. Key March of Dimes policy priorities include access to health care for all women of childbearing age and children; research into prematurity, birth defects, and other aspects of reproductive and child health and development; prevention and health promotion issues, such as tobacco cessation and nutrition; and issues of concern to the operation of not-for-profit organizations. Prior to joining March of Dimes, Ms. Pellegrini served as Associate Director for Federal Affairs at the American Academy of Pediatrics, where she covered a range of issues including genetics, bioethics, child abuse and neglect, environmental health, nutrition, obesity, and injury and violence. In this capacity, Ms. Pellegrini worked with AAP leadership to develop and execute strategies to advance AAP priorities through both Congress and the Administration. Ms. Pellegrini worked on Capitol Hill for over eleven years.  From 1996 to 2004, she served as Chief of Staff and health aide to Rep. Louise Slaughter (NY). Her tenure on Capitol Hill also included stints with Reps. Gerald Kleczka (WI) and Jay Inslee (WA). She has published on trends in federal public health and preparedness spending and served on the National Commission on Children and Disasters’ Pediatric Medical Care Subcommittee. Ms. Pellegrini has an extensive background in public policy issues as well as politics and administration.

Share this:

[niman]

Celeste Philip

Dr. Philip was a participant for the Forum’s discussion on Zika in the U.S., Puerto Rico, and Beyond.

Celeste Philip, MD, MPH, was appointed by Governor Rick Scott as Surgeon General and Secretary on May 18, 2016. Most recently, she served as the Interim Surgeon General and prior to that as the Deputy Secretary for Health and Deputy State Health Officer for Children’s Medical Services. Dr. Philip, who is board certified in Family Medicine as well as Preventive Medicine and Public Health, brings a wealth of academic excellence and professional experience with her.

Dr. Philip has served as interim director for three county health departments, and as interim bureau chief for the Department’s Bureau of Communicable Diseases. In addition, she was medical director for the Department in Polk County. While in Lakeland, she chaired the Polk Health Care Alliance Infrastructure Committee and served on the board of the Lakeland Volunteers in Medicine, through which she provided primary care to uninsured patients.

Dr. Philip is a board member of the Florida Healthy Kids Corporation and on the Health Initiatives Committee Advisory Group to the Florida Board of Governors. Dr. Philip is board certified in family medicine as well as preventive medicine and public health.

Dr. Philip’s contributions to public health are not limited to Florida. She is president-elect of the American Heart Association’s six-state Greater Southeast Affiliate. Dr. Philip served at the Centers for Disease Control and Prevention (CDC) as an Epidemic Intelligence Service officer.

Dr. Philip graduated from Howard University in Washington DC magna cum laude, with a Bachelor’s Degree in English and Spanish. She later received a Master of Public Health in maternal and child health and a Doctor of Medicine from Loma Linda University in California. She completed her residency at Florida Hospital in Orlando and has remained committed to improving health in Florida throughout her career.